Genetic Variants in DNA Repair Pathways as Potential Biomarkers in Predicting Treatment Outcome of Intraperitoneal Chemotherapy in Patients With Colorectal Peritoneal Metastasis: A Systematic Review

BACKGROUND: The introduction of cytoreductive surgery (CRS) followed by hyperthermic intraperitoneal chemotherapy (HIPEC) with either oxaliplatin or mitomycin C for patients with colorectal peritoneal metastasis (CPM) has resulted in a major increase in overall survival. Nonetheless, despite critica...

Descripción completa

Detalles Bibliográficos
Autores principales: Hulshof, Emma C., Lim, Lifani, de Hingh, Ignace H. J. T., Gelderblom, Hans, Guchelaar, Henk-Jan, Deenen, Maarten J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7575928/
https://www.ncbi.nlm.nih.gov/pubmed/33117169
http://dx.doi.org/10.3389/fphar.2020.577968

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7575928/
https://www.ncbi.nlm.nih.gov/pubmed/33117169
http://dx.doi.org/10.3389/fphar.2020.577968

Ejemplares similares